Cor Vasa 2017, 59(2):e119-e127 | DOI: 10.1016/j.crvasa.2016.11.013
The risk profile of patients with acute coronary syndrome treated at IKEM between 2006 and 2013
- a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
- b Laboratoř pro výzkum aterosklerózy, Institut klinické a experimentální medicíny, Praha, Česká republika
- c Oddělení biostatistiky, Institut klinické a experimentální medicíny, Praha, Česká republika
- d Centrum kardiovaskulární prevence, 1. lékařská fakulta Univerzity Karlovy a Thomayerova nemocnice, Praha, Česká republika
The proportion and, possibly, also the relevance of some cardiovascular risk factors at the population level are changing. The aim of the present study was to characterize the current risk profile of patients with acute coronary syndrome (ACS) and to compare their data with those obtained from an identical population.
Included in the study were 946 men aged 28-65 years and 296 women aged 30-70 years, admitted to the Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, with the diagnosis of ACS between 2006 and 2013. The incidence of risk factors in patients was compared with that identified in an age-matched population sample examined within Czech post-MONICA, a survey conducted in the 2006-2009 period.
Compared with a control group of 1400 men and 1016 women, all risk factors except for total cholesterol were more frequently present in the patients. Men and women with ACS showed similar total cholesterol levels (men 5.41 ± 1.16 mmol/l vs 5.50 ± 1.08 mmol/l; NS; women 5.60 ± 1.25 mmol/l vs 5.71 ± 1.01 mmol/l; NS; respectively), but higher LDL-cholesterol (LDLc) levels (men 3.66 ± 1.05 mmol/l vs 3.38 ± 0.93 mmol/l; p < 0.001; women 3.67 ± 1.17 mmol/l vs 3.45 ± 0.91 mmol/l; p < 0.001, respectively) and lower HDL-cholesterol (HDLc) levels (men 1.14 ± 0.31 mmol/l vs 1.28 ± 0.34 mmol/l; p < 0.001; women 1.32 ± 0.37 mmol/l vs 1.60 ± 0.38 mmol/l; p < 0.001, respectively). These differences persisted even after excluding patients and controls on statin therapy. A more detailed analysis of the lipid profile by age groups revealed bigger differences between patients and controls in LDLc levels (particularly in younger patients), whereas HDLc levels were low in all age groups. Thus, the LDLc/HDLc ratio remains higher in patients than in controls irrespective of age.
A positive family history of premature ACS was likewise present more often in patients (men 19.8% vs 13.9%; p < 0.001; women 25.9% vs 18.4%; p < 0.001), with the differences being bigger in younger patients. In patients with a positive family history, ACS manifested itself at a younger age; the differences between age groups became more marked in cases where a positive family history was associated with smoking or hypertension. Men with ACS and a positive family history differed from the other patients only in a higher proportion of those with low (< 1.0 mmol/l) HDLc (55.5 vs 45.0 %; p < 0.05 mmol/l) and higher body mass index (BMI) (29.27 ± 4.79 vs 28.49 ± 4.29 kg/m2; p < 0.05).
At present, total cholesterol levels do not seem to be a risk factor for ACS in the general population. The risk seems to be highest in smokers and those with low LDLc and/or increased LDLc/HDLc ratio. In younger patients, additional risk factors include a positive family history of premature coronary heart disease (CHD) and higher LDLc levels.
Keywords: Acute coronary syndrome; Age groups; Lipids; Traditional risk factors of CHD
Received: September 29, 2016; Accepted: November 29, 2016; Published: April 1, 2017 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- R. Cífková, Z. Škodová, J. Bruthans, et al., Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA, Atherosclerosis 211 (2010) 676-681.
Go to original source...
Go to PubMed...
- J. Piťha, J.A. Hubáček, R. Poledne, et al., Genetic determination of the prognosis in survivors of the acute coronary syndromes. Study design and rationale for multicentred study, Cor et Vasa 49 (2007) 134-137.
Go to original source...
- H. Tunstall-Pedoe, K. Kuulasmaa, H. Tolonen, et al., in: H. Tunstal-Pedoe (Ed.), MONICA Monograph and Multimedia Sourcebook, World Health Organisation, Geneva, 2003.
- T.R. Dawber, W.B. Kannel, N. Revotskie, et al., The epidemiology of coronary heart disease - the Framingham enquiry, Proceedings of the Royal Society of Medicine 55 (1962) 265-271.
Go to original source...
Go to PubMed...
- T. Gordon, W.P. Castelli, M.C. Hjortland, et al., High density lipoprotein as a protective factor against coronary heart disease. The Framingham study, American Journal of Medicine 62 (1977) 707-714.
Go to original source...
Go to PubMed...
- W.B. Kannel, D.L. McGee, Diabetes and cardiovascular disease. The Framingham study, Journal of the American Medical Association 241 (1979) 2035-2038.
Go to original source...
Go to PubMed...
- J.M. Schildkraut, R.H. Myers, L.A. Cupples, et al., Coronary risk associated with age and sex of parental heart disease in the Framingham study, American Journal of Cardiology 64 (1989) 555-559.
Go to original source...
Go to PubMed...
- L.S. Geiss, J. Wang, Y.J. Cheng, et al., Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012, Journal of the American Medical Association 312 (2014) 1218-1226.
Go to original source...
Go to PubMed...
- Long-term Trends in Diabetes, CDC's Division of Diabetes Translation, National surveillance System, 2014, October, available at http://www.cdc.gov./diabetes/statistic.
- J.B. Rubin, W.B. Borden, Coronary heart disease in young adults, Current Atherosclerosis Reports 14 (2012) 140-149.
Go to original source...
Go to PubMed...
- R. Roberts, A.F. Stewart, Genes and coronary artery disease: where are we?, Journal of the American College of Cardiology 60 (2012) 1715-1721.
Go to original source...
Go to PubMed...
- J.A. Hubacek, V. Staněk, M. Gebauerová, et al., Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians, Experimental and Clinical Cardiology 15 (3) (2010) e52-e56.
Go to PubMed...
- R. Poledne, J.A. Hubáček, V. Staněk, et al., Why we are not able to find the coronary heart disease gene - apoE as an example, Folia Biologica (Prague) 56 (2010) 218-222.
Go to PubMed...
- P.J. Talmud, Gene-environment interaction and its impact on coronary heart disease risk, Nutrition, Metabolism and Cardiovascular Diseases 17 (2007) 148-152.
Go to original source...
Go to PubMed...
- J. Bruthans, R. Cífková, V. Lánská, et al., Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007, European Journal of Preventive Cardiology 21 (2014) 829-839.
Go to original source...
Go to PubMed...
- J. Reissigová, M. Tomečková, Intervence rizikových faktorů aterosklerózy a kardiovaskulární úmrtnost. 20letá primárně preventivní studie z pohledu statistika, Cor et Vasa 45 (2003) 249-255.
- J. Stamler, D. Wentworth, J.D. Neaton, for the MRFIT Research Group, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 22 primary screenees of the multiple risk factor intervention trial (MRFIT), Journal of the American Medical Association 256 (1986) 2823-2828.
Go to original source...
Go to PubMed...
- U. Goldbourt, S. Yaari, J.H. Medalie, Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21 year follow-up of 8000 men, Arteriosclerosis, Thrombosis and Vascular Biology 17 (1997) 107-113.
Go to original source...
Go to PubMed...
- G. Assmann, H. Schulte, A. vom Eckardstein, Y. Huang, High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport, Atherosclerosis 124 (1996) S11-S20.
Go to original source...
Go to PubMed...
- V. Staněk, R. Cífková, M. Gebauerová, et al., Měnící se spektrum rizikových faktorů ischemické choroby srdeční, Cor et Vasa 51 (2009) 685-690.
Go to original source...
- M. Mulder, P. Lombardi, H. Jansen, Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase, Journal of Biological Chemistry 268 (1993) 9369-9375.
Go to original source...
- M. Sewardsen, S. Vythlingum, I. Jialal, R. Nadar, Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction, Postgraduate Medical Journal 64 (1988) 352-369.
Go to original source...
Go to PubMed...
- H. Chamsi-Pasha, R.J. Taylor, D. McDowell, P.C. Barnes, Plasma lipids: when to measure after myocardial infarction?, British Journal of General Practice 43 (1989) 447-450.
Go to original source...
- B. Pitt, J. Loscalzo, J.S. Raichlen, Lipid levels after acute coronary syndromes, Journal of the American College of Cardiology 51 (2008) 1440-1445.
Go to original source...
Go to PubMed...
- N. Wattanasuwan, I.A. Khan, R.M. Gowda, et al., Effect of acute myocardial infarction on cholesterol ratios, Chest 120 (2001) 1196-1199.
Go to original source...
Go to PubMed...
- M. Grundtvig, T.P. Hagen, M. German, A. Reikvam, Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men, European Journal of Preventive Cardiology 16 (2009) 174-179.
Go to original source...
Go to PubMed...